Agenda Topics- Drug discovery technology transfer
- European lead generation and enabling open innovation
- Novel approaches across different therapeutic areas
- Partnering models for academia and industry
- Professional translational research
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to dateJulian Blagg, Deputy Director, Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research Patrick Chaltin, Director, K U Leuven Research & Development Kurt Deshayes, Senior Scientist, Early Discovery Biochemistry, Genentech Tim Hammonds, Deputy Director Drug Discovery, Cancer Research Technology Trevor Howe, Director, Johnson & Johnson Phil Jones, Director, European Screening Centre Newhouse, University of Dundee Mark Moloney, Professor of Chemistry, University of Oxford Susanne Muller Knapp, Group Head Structural Genomics Consortium (SGC), University Of Oxford Niclas Nilsson, Open Innovation Manager, LEO Pharma Peter Nussbaumer, Managing Director, Lead Discovery Center GmbH Garry Pairaudeau, Global Head of Research Outsourcing, AstraZeneca John Spencer, Professor, University of Sussex
|